Posted on October 10th, 2011 by Health News
United Therapeutics Corporation announced that its subsidiary, Unither Virology, LLC, has been awarded a contract for up to approximately $45 million under a Broad Agency Announcement from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for studies directed at the development of a broad-spectrum antiviral drug [...]
No Comments »
Filed under: Pharmacy News
Posted on October 10th, 2011 by Health News
Pharmasset, Inc. announced today the addition of two treatment arms to the ELECTRON trial of PSI-7977, a nucleotide analog polymerase inhibitor, for the treatment of chronic hepatitis C.
No Comments »
Filed under: Pharmacy News
Posted on October 10th, 2011 by Health News
Cardium Therapeutics announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the Company’s new Excellagen™ professional-use, sterile, syringe-based advanced wound care product for the management of diabetic foot ulcers and other dermal wounds.
No Comments »
Filed under: Pharmacy News
Posted on October 10th, 2011 by Health News
Inovio Pharmaceuticals, Inc., a leader in the development of synthetic vaccines against cancers and infectious diseases, announced today that it has entered into a product development collaboration agreement with its affiliate, VGX International Inc., to co-develop Inovio’s SynCon therapeutic vaccines for hepatitis B and C infections.
No Comments »
Filed under: Pharmacy News
Posted on October 10th, 2011 by Health News
Novo Nordisk has today announced the launch of their new disposable prefilled insulin pen - FlexTouch - in the UK. FlexTouch is available in the UK with Novo Nordisk’s rapid-acting modern insulin analogue NovoRapid.
No Comments »
Filed under: Pharmacy News
Posted on October 10th, 2011 by Health News
A new study has found that an osteoporosis drug protects against the bone damaging side effects of certain breast cancer medications. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that some breast cancer patients could take zoledronic acid in addition to their anti-cancer medications to maintain bone [...]
No Comments »
Filed under: Pharmacy News
Posted on October 10th, 2011 by Health News
Modern medicine’s ability to save lives through organ transplantation has been revolutionized by the development of drugs that prevent the human body from rejecting the transplanted organ.
No Comments »
Filed under: Pharmacy News
Posted on October 10th, 2011 by Health News
Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved COMBIVENT RESPIMAT, a new, propellant-free inhaler product that uses a slow-moving mist to deliver the same active ingredients of COMBIVENT Inhalation Aerosol in a metered dose inhaler.
No Comments »
Filed under: Pharmacy News
Posted on October 10th, 2011 by Health News
Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved JUVISYNC(sitagliptin and simvastatin), a new treatment for type 2 diabetes that combines the glucose-lowering medication sitagliptin, the active component of JANUVIA (sitagliptin), with the cholesterol-lowering medication ZOCOR.
No Comments »
Filed under: Pharmacy News
Posted on October 10th, 2011 by Health News
Parents of young caffeine consumers take heed: that high-calorie energy drink or soda might present more than just obesity risk. In fact, according to a double-blind, placebo-controlled study that examined responses to stimulants, an individual’s subjective response to caffeine may predict how he or she will respond to other stimulant drugs, possibly reflecting differences in [...]
No Comments »
Filed under: Pharmacy News
